Filter
274
Text search:
second
booster
Featured
Recommendations
24
New Publications
61
Language
Document type
No document type
125
Guidelines
65
Studies & Reports
33
Manuals
14
Fact sheets
14
Strategic & Response Plan
10
Training Material
5
Situation Updates
4
Brochures
3
Resource Platforms
1
Countries / Regions
India
16
Global
14
South Africa
7
Philippines
6
Congo, Democratic Republic of
5
Zambia
5
Nigeria
4
Tanzania
4
Namibia
4
Africa
4
Ghana
3
Kenya
3
Ukraine
3
Lesotho
3
Western and Central Europe
3
Liberia
2
Uganda
2
Zimbabwe
2
Nepal
2
Rwanda
2
Mozambique
2
Brazil
2
East and Southern Africa
2
Latin America and the Carribbean
2
Sierra Leone
1
Senegal
1
Ethiopia
1
Germany
1
Indonesia
1
Benin
1
Argentina
1
Colombia
1
Botswana
1
Myanmar / Burma
1
South–East Asia Region
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Fiji
1
Venezuela
1
Eastern Europe
1
Moldova
1
France
1
Authors & Publishers
Publication Years
Category
Countries
87
Clinical Guidelines
47
Women & Child Health
19
Public Health
15
Key Resources
9
Capacity Building
3
Pharmacy & Technologies
1
Toolboxes
COVID-19
51
HIV
23
Mental Health
15
TB
11
Polio
9
Pharmacy
7
NTDs
7
Conflict
6
Rapid Response
6
Caregiver
6
Refugee
5
Planetary Health
5
Malaria
5
Ebola & Marburg
4
NCDs
3
Disability
2
Cholera
2
Natural Hazards
2
Global Health Education
2
AMR
2
Health Financing Toolbox
2
Specific Hazards
1
September 2021
This document aims to provide interim guidance for microbiology and virology experts, other laboratory professionals, laboratory managers, infectious disease programme managers, public health professionals and other stakeholders that provide primary, confirmatory or advanced testing for SARS-CoV-2,
...
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im
...
The publication of the Second Edition of the Emergency Drug Guidelines represents the culmination of the efforts of the National Drugs and Therapeutics Committee (NDTC) to publish clinical drug guidelines for common diseases seen in Fiji. These guid
...
Education material for teachers of midwifery
Midwifery education modules - second edition
This global guidance provided the framework for over 100 countries to develop their NDVPs. This updated (second) version supersedes the previous version published in 16 November 2020. New information has been added on the following areas:
th
...
The objective of Health in the Americas: Overview of the Region of the Americas in the Context of the COVID-19 Pandemic is to respond to the need to address important public health issues in an increasingly timely manner, while serving as a platform with a close focus on specific issues of regional
...
Weekly epidemiological recordRelevé épidémiologique hebdomadaire 3 MAY 2024, 99th YEAR / 3 MAI 2024, 99e ANNÉE
No 18, 2024, 99, 203–224
The WHO position papers are concerned primarily with the use of vaccines in large-scale vaccination programmes.
The position papers are intended for use by
...
Overview
16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an mRNA vaccine).
Interim guidance, 26 October 2021
This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 5 October 2021.
SAGE said moderately and severely immunocompromised persons should be offered an addition
...
Bisher hat die STIKO empfohlen, dass alle im Ausland mit einem nicht in der EU zugelassenen Impfstoff geimpften Personen eine erneute Impfserie mit einem in der EU zugelassenen Impfstoff erhalten sollen. Ziel der im Epidemiologischen Bulletin 13/2022 veröffentlichten aktualisierten COVID-19-Impfemp
...
31 March 2021
This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained series.
Vaccines are a critical tool in the battl
...
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat
...
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc
...
